Over some four weeks, 1,066 people with multiple myeloma took part in a survey sponsored by HealthTree to better understand how COVID-19 is affecting life for those with this blood cancer. The survey, announced on April 16, aims to provide patients and physicians with information that will help guide future healthcare decisions. It assesses myeloma patient vulnerability, and the effect of the ongoing pandemic on treatment and disease outcomes. Initial findings are expected to be released this month,…
You must be logged in to read/download the full post.
The post 1,066 Myeloma Patients Answer HealthTree Survey of COVID-19’s Effects appeared first on BioNewsFeeds.